TrialClinical genitourinary cancer2026

Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo.

Douglas G McNeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.